Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Free Cash Flow (2016 - 2026)

Exicure's (XCUR) quarterly Free Cash Flow came in at -$1.1 million in Q1 2026, up 28.54% YoY from -$888469.3 in Q1 2025, and down 131.64% on a QoQ basis from -$493000.0 in Q4 2025.

Exicure (XCUR) Free Cash Flow (2016 - 2026) Analysis & Trends

Exicure (XCUR) has 11 years of Free Cash Flow data on file, last reported at -$1.1 million in Q1 2026.

  • Quarterly Free Cash Flow rose 28.54% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.8 million (down 91.72% YoY) and the FY2025 annual result came in at -$8.6 million, down 194.02% from the prior year.
  • Free Cash Flow eased to -$1.1 million in Q1 2026, from -$493000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$449000.0 in Q3 2024 to a low of -$12.8 million in Q1 2022.
  • A 5-year average of -$3.4 million and a median of -$1.6 million in 2025 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2024 — Free Cash Flow surged 85.66% — and 2025, when it plunged 760.36%.
  • Tracing XCUR's Free Cash Flow over 5 years: stood at -$7.3 million in 2022, then surged by 85.31% to -$1.1 million in 2023, then grew by 20.95% to -$845000.0 in 2024, then soared by 41.66% to -$493000.0 in 2025, then sank by 131.64% to -$1.1 million in 2026.
  • The last three Free Cash Flow figures came in at -$1.1 million (Q1 2026), -$493000.0 (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Exicure 7.27 Mn 7.27 Mn - -887,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.14 Mn
Mar 31, 2026 -1.14 Mn
Dec 31, 2025 -493,000.00
Dec 31, 2025 -493,000.00
Sep 30, 2025 -3.86 Mn
Sep 30, 2025 -3.86 Mn
Jun 30, 2025 -2.28 Mn
Jun 30, 2025 -2.28 Mn
Mar 31, 2025 -1.60 Mn
Mar 31, 2025 -1.60 Mn
Dec 31, 2024 -845,000.00
Dec 31, 2024 -845,000.00
Sep 30, 2024 -449,000.00
Sep 30, 2024 -449,000.00
Jun 30, 2024 -1.17 Mn
Jun 30, 2024 -1.17 Mn
Mar 31, 2024 -450,000.00
Mar 31, 2024 -450,000.00
Dec 31, 2023 -1.07 Mn
Dec 31, 2023 -1.07 Mn